当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 资产负债表

共同药业

(300966)

  

流通市值:13.96亿  总市值:20.99亿
流通股本:7666.50万   总股本:1.15亿

资产负债表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
流动资产:
货币资金157,140,791.92141,181,205.23130,486,537.6304,299,912.31
应收票据及应收账款234,723,715.07204,637,654.13202,188,554.48212,699,394.34
其中:应收票据22,515,024.5315,969,258.0521,645,710.6216,020,652.52
应收账款212,208,690.54188,668,396.08180,542,843.86196,678,741.82
应收款项融资6,061,995.649,623,992.217,829,570.5816,624,976.97
预付款项17,908,414.110,721,612.321,848,248.5722,486,158.22
其他应收款合计3,674,702.792,052,867.782,849,325.932,526,389.92
存货433,172,804.78384,797,242.09383,824,667.7389,561,155.94
其他流动资产19,741,864.3216,981,792.759,294,465.2335,189,348.7
流动资产平衡项目0000
流动资产合计872,425,299.25769,997,377.12758,322,380.59983,388,346.9
非流动资产:
长期股权投资48,320,488.0248,268,996.2348,553,666.1448,489,605.54
投资性房地产17,857,043.0318,014,552.8418,172,062.6518,329,572.46
固定资产1,130,257,222.261,154,486,627.36858,214,432.4517,696,778.25
在建工程730,989,301.94694,413,010.74856,414,467.391,056,597,331.03
使用权资产56,701.2770,876.685,051.9399,227.26
无形资产49,602,459.6849,881,065.9650,159,672.2450,438,278.52
长期待摊费用8,804,934.489,618,102.3610,211,801.2211,295,204.51
递延所得税资产40,913,423.5637,290,872.1533,834,680.9428,404,434.39
其他非流动资产14,325,689.357,838,847.563,284,979.5257,735,036.45
非流动资产平衡项目0000
非流动资产合计2,041,127,263.592,019,882,951.741,938,930,814.431,789,085,468.41
资产平衡项目0000
资产总计2,913,552,562.842,789,880,328.862,697,253,195.022,772,473,815.31
流动负债:
短期借款291,238,917.77294,303,069.17252,273,011.1236,267,427.78
应付票据及应付账款465,690,482.39459,913,423.7477,989,551.83510,116,706.26
其中:应付票据57,464,804.437,117,95671,474,971.0489,368,286.02
应付账款408,225,677.99422,795,467.7406,514,580.79420,748,420.24
预收款项472,660.5547,266.05212,697.27354,495.42
合同负债2,104,842.751,226,484.651,192,191.8806,793.58
应付职工薪酬6,368,448.769,514,285.45,253,938.754,694,463.57
应交税费401,178.932,844,802.32,838,439.77874,849.5
其他应付款合计837,504.88899,641.66796,833.2700,375.33
一年内到期的非流动负债28,454,955.2324,609,710.8621,444,124.3925,931,392.38
其他流动负债31,756,083.3914,328,360.4420,000,302.0129,132,804.43
流动负债平衡项目0000
流动负债合计827,325,074.65807,687,044.23782,001,090.12808,879,308.25
非流动负债:
长期借款586,151,083.35484,919,646.66420,963,408.74502,078,507.11
应付债券333,989,211.11327,722,176.41321,446,330.06315,135,143.87
租赁负债--00
预计负债4,648,020.474,648,020.47030,002.5
递延收益149,362,080.36150,250,753.02141,389,053.67105,495,251
递延所得税负债12,760.9710,633.0812,759.3614,884.09
非流动负债平衡项目0000
非流动负债合计1,074,163,156.26967,551,229.64883,811,551.83922,753,788.57
负债平衡项目0000
负债合计1,901,488,230.911,775,238,273.871,665,812,641.951,731,633,096.82
所有者权益(或股东权益):
实收资本(或股本)115,279,416115,279,416115,279,306115,279,306
其他权益工具96,489,947.3696,489,947.3696,490,723.0996,490,723.09
资本公积410,706,015.42410,599,708.03412,259,985.75412,019,125.25
减:库存股1,921,250.12---
盈余公积9,953,911.259,953,911.259,861,298.499,861,298.49
未分配利润291,896,774.85290,814,696.93304,336,230.59313,379,855.2
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计922,404,814.76923,137,679.57938,227,543.92947,030,308.03
少数股东权益89,659,517.1791,504,375.4293,213,009.1593,810,410.46
股东权益平衡项目0000
股东权益合计1,012,064,331.931,014,642,054.991,031,440,553.071,040,840,718.49
负债和股东权益合计2,913,552,562.842,789,880,328.862,697,253,195.022,772,473,815.31
公告日期2025-04-292025-04-242024-10-242024-08-28
审计意见(境内)标准无保留意见
TOP↑